Grade 3 Hepatotoxicity following Fulvestrant, Palbociclib, and Erdafitinib Therapy in a Patient with ER-Positive/PR-Negative/HER2-Negative Metastatic Breast Cancer: A Case Report

Abstract Uma mulher de 49 anos com câncer de mama metastático ER-positivo/PR-negativo/HER2-negativo experimentou hepatotoxicidade de grau 3 após o início

Continue readingGrade 3 Hepatotoxicity following Fulvestrant, Palbociclib, and Erdafitinib Therapy in a Patient with ER-Positive/PR-Negative/HER2-Negative Metastatic Breast Cancer: A Case Report